Pharmacological therapy of dysthymia
Data up to Jan 2025
Total Citations Per Year
Abstract
References (40)
Depression and Parkinson's disease: a review
1992 • 1,110 citations
Time to Recovery, Chronicity, and Levels of Psychopathology in Major Depression
1992 • 852 citations
Characterological Depressions
1980 • 334 citations
Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial
1988 • 280 citations
"Double depression": two-year follow-up
1983 • 259 citations
Thymosthenic effects of ritanserin (R 55667), a centrally acting serotonin‐S2 receptor blocker
1986 • 194 citations
Imipramine Treatment for Chronic Depression
1988 • 178 citations
A randomized double-blind study of fluoxetine versus placebo in the treatment of dysthymia
1993 • 143 citations
Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
1982 • 134 citations
Phenelzine and Amitriptyline: Effects on Symptoms of Neurotic Depression
1982 • 100 citations
Pharmacotherapy of Dysthymia
1991 • 99 citations
Social functioning in chronic depression: Effect of 6 weeks of antidepressant treatment
1988 • 92 citations
Efficacy of moclobemide in different patient groups: a meta-analysis of studies
1992 • 88 citations
5‐HT2 receptor antagonism in dysthymic disorder: a double‐blind placebo‐controlled study with ritanserin
1991 • 82 citations
Imipramine and social-vocational adjustment in chronic depression
1988 • 78 citations
Double-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic Disorders
1987 • 64 citations
Phenelzine for chronic depression: a study of continuation treatment.
1986 • 64 citations
Ritanserin, Imipramine, and Placebo in the Treatment of Dysthymic Disorder
1993 • 57 citations
Imipramine for treatment of chronic depression.
1985 • 40 citations
A preliminary study of serotonergic antidepressants in treatment of dysthymia
1992 • 39 citations
Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
1989 • 39 citations
Therapeutic Efficacy of Specific Serotonin Reuptake Inhibitors (SSRIs) in Dysthymia
1994 • 39 citations
Prediction of response of chronic depression to imipramine
1989 • 35 citations
Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment
1991 • 29 citations
Dependence on Monoamine Oxidase Inhibitors in High Dose
1991 • 26 citations
Tolerance to phenelzine and subsequent refractory depression: three cases.
1989 • 25 citations
Pharmacotherapy of Dysthymia
1993 • 24 citations
A Review of Treatment Studies of Minor Depression: 1980–1991
1992 • 24 citations
Sodium Valproate as an Antidepressant
1992 • 22 citations
Fengabine, a New GABAmimetic Agent in the Treatment of Depressive Disorders: An Overview of Six Double-Blind Studies versus Tricyclics
1988 • 21 citations
Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium
1990 • 20 citations
Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: II. Urinary metabolites of serotonin, norepinephrine, epinephrine and melatonin
1994 • 13 citations
A Systematic Approach to the Classification and Pharmacotherapy of Nonpsychotic Major Depression and Dysthymia
1993 • 12 citations
Alprazolam and amitriptyline in the treatment of moderate depression
1994 • 12 citations
Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test
1994 • 11 citations
Recurrent brief depression, dysthymia and melancholia
1993 • 8 citations
Recognition and management of dysthymic disorder.
1989 • 4 citations
A comparison of clomipramine and doxepin in neurotic depression.
1984 • 3 citations
A comparison of clomipramine and doxepin in neurotic depression
1985 • 3 citations
BIOCHEMICAL MEASURES IN PRIMARY EARLY ONSET DYSTHYMIC DISORDER
1992 • 1 citations